Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 68 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 6566500

    Compositions and methods for modifying toxic effects of proteinaceous compounds

    The Board of Regents of the University of Texas System · Granted May 20, 2003 · Expires May 15, 2023

    expired

  2. US 6562801

    PpGpp and pppGpp as immunomodulatory agents

    The Board of Regents of the University of Texas System · Granted May 13, 2003 · Expires May 8, 2023

    expired

  3. US 6551774

    Diagnostic methods for conditions associated with elevated cellular levels of telomerase activity

    The Board of Regents of the University of Texas System · Granted Apr 22, 2003 · Expires Apr 17, 2023

    expired

  4. US 6551830

    Rh blood group antigen compositions and methods of use

    The Board of Regents of the University of Texas System · Granted Apr 22, 2003 · Expires Apr 17, 2023

    expired

  5. US 6537804

    BCR-ABL directed compositions and uses for inhibiting Philadelphia chromesome stimulated cell growth

    The Board of Regents of the University of Texas System · Granted Mar 25, 2003 · Expires Mar 20, 2023

    expired

  6. US 6524583

    Antibody methods for selectively inhibiting VEGF

    The Board of Regents of the University of Texas System · Granted Feb 25, 2003 · Expires Feb 20, 2023

    expired

  7. US 6517828

    C-CAM as an angiogenesis inhibitor

    The Board of Regents of the University of Texas System · Granted Feb 11, 2003 · Expires Feb 6, 2023

    expired

  8. US 6518063

    Osf2/Cbfa1 nucleic acids and methods of use therefor

    The Board of Regents of the University of Texas System · Granted Feb 11, 2003 · Expires Feb 6, 2023

    expired

  9. US 6515118

    DNA fragmentation factor

    The Board of Regents of the University of Texas System · Granted Feb 4, 2003 · Expires Jan 30, 2023

    expired

  10. US 6514942

    Methods and compositions for stimulating T-lymphocytes

    The Board of Regents of the University of Texas System · Granted Feb 4, 2003 · Expires Jan 30, 2023

    expired

  11. US 6511847

    Recombinant p53 adenovirus methods and compositions

    The Board of Regents of the University of Texas System · Granted Jan 28, 2003 · Expires Jan 23, 2023

    expired

  12. US 6509319

    EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections

    The Board of Regents of the University of Texas System · Granted Jan 21, 2003 · Expires Jan 16, 2023

    expired

  13. US 6509317

    Method of treating chronic cardiac disease

    The Board of Regents of the University of Texas System · Granted Jan 21, 2003 · Expires Jan 16, 2023

    expired

  14. US 6503915

    Composition and method for treatment of cerebral ischemia

    The Board of Regents of the University of Texas System · Granted Jan 7, 2003 · Expires Jan 2, 2023

    expired

  15. US 6503916

    Treatment of ischemic brain injury

    The Board of Regents of the University of Texas System · Granted Jan 7, 2003 · Expires Jan 2, 2023

    expired

  16. US 6503498

    Apolipoprotein A-1 adenovirus vector compositions and methods

    The Board of Regents of the University of Texas System · Granted Jan 7, 2003 · Expires Jan 2, 2023

    expired

  17. US 6503914

    Thienopyrimidine-based inhibitors of the Src family

    The Board of Regents of the University of Texas System · Granted Jan 7, 2003 · Expires Jan 2, 2023

    expired

  18. US 6500834

    Composition and method for treatment of cerebral ischemia

    The Board of Regents of the University of Texas System · Granted Dec 31, 2002 · Expires Dec 26, 2022

    expired

  19. US 6500798

    Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress regulators

    The Board of Regents of the University of Texas System · Granted Dec 31, 2002 · Expires Dec 26, 2022

    expired

  20. US 6492104

    EIA test using nondenatured HIV antigen for early detection of HIV infection

    The Board of Regents of the University of Texas System · Granted Dec 10, 2002 · Expires Dec 5, 2022

    expired

  21. US 6489163

    Ribozyme mediated inactivation of the androgen receptor

    The Board of Regents of the University of Texas System · Granted Dec 3, 2002 · Expires Nov 28, 2022

    expired

  22. US 6486166

    Suppression of cyclin kinase 2 activity for prevention and treatment of DNA viral infections

    The Board of Regents of the University of Texas · Granted Nov 26, 2002 · Expires Nov 21, 2022

    expired

  23. US 6482795

    Tumor suppressor designated TS10q23.3

    The Board of Regents of the University of Texas System · Granted Nov 19, 2002 · Expires Nov 14, 2022

    expired

  24. US 6482803

    Modification of mutated P53 gene in tumors by retroviral delivery of ribozyme A

    The Board of Regents of the University of Texas System · Granted Nov 19, 2002 · Expires Nov 14, 2022

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.